Hannover House, Inc.
HHSE · OTC
9/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.00 | 0.00 | -0.62 |
| FCF Yield | 0.00% | 0.00% | 0.00% | 0.00% |
| EV / EBITDA | 470.63 | 66.87 | 537.06 | 160.94 |
| Quality | ||||
| ROIC | 0.06% | 0.38% | 0.06% | 0.13% |
| Gross Margin | 93.77% | 80.80% | 90.29% | 96.96% |
| Cash Conversion Ratio | 2.71 | -55.06 | 2.22 | 0.62 |
| Growth | ||||
| Revenue 3-Year CAGR | 3.18% | 54.66% | 43.29% | 30.49% |
| Free Cash Flow Growth | 0.00% | 0.00% | 0.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | 69.76 | 11.66 | 77.23 | 30.56 |
| Interest Coverage | 1.08 | 5.86 | 1.06 | 2.11 |
| Efficiency | ||||
| Inventory Turnover | 0.05 | 0.49 | 0.07 | 0.03 |
| Cash Conversion Cycle | 3,201.26 | 954.33 | 3,299.87 | 3,918.59 |